Nebulizer, Oxygen Cylinders… Govt Allows Import Of Medical Devices For 3 Months With Riders

New Delhi : The government has given permission to import 17 medical devices, including, nebulizer, oxygen concentrators, oxygen cannister, oxygen cylinders, oxygen generators and ventilators for three months with mandatory declarations immediately after custom clearance and before sale of such products in the domestic market.

An order in this regard has been issued by the Food and Consumer Affairs Ministry.

“Government under the leadership of PM@ Narendra Modiji permits importers of medical devices for making mandatory declarations required under Legal Metrology Rules, 2011 after custom clearance and before the sale,” Food and Consumer Affairs Minister Piyush Goyal tweeted.

This will help fulfill the country’s demand of medical devices required for Covid-19, he added.

Due to the prevalent pandemic situation of Covid-19, the ministry in its April 28 order said, there is a steep demand for medical devices in these critical conditions on an urgent basis in view of the emergent health concerns and immediate supply of the medical industry.

Therefore,, considering the pandemic situations of Covi-19 and to meet the demand of medical devices, the Central Govt under the Legal Metrology (Packaged Commodities) Rules, 2011 “hereby permits the importers of medical devices to import the…medical devices for three months from the date of this advisory.”

Imports of medical devices have been permitted subject to a condition that importers will make all declarations (by way of stamping or putting stickers or online printing) required under the Rules immediately after import/custom clearance and before sale of such products in the domestic market, the order said.

Importers have been asked to inform the quantity of imported  medical devices to state governments where import is made, immediately after the shipment, it added.

The move comes amid a crippling shortage of oxygen supply in the wake of rise in Covid-19 cases in the second wave of the COVID-19 pandemic.

[pdf-embedder url=”https://medicarepharmabusiness.com/wp-content/uploads/2021/04/Permission-medical-devices-19-28.4.2021-300421084056.pdf” title=”Permission medical devices 19 28.4.2021-300421084056″]

  • Related Posts

    Diabetic drug metformin found to act on brain

    NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

    Hetero debuts semaglutide generic in emerging markets

    New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Diabetic drug metformin found to act on brain

    Diabetic drug metformin found to act on brain

    Hetero debuts semaglutide generic in emerging markets

    Hetero debuts semaglutide generic in emerging markets

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework